共 18 条
[11]
Van Nagell J.R., DePriest P.D., Gallion H.H., Pavlik E.J., Ovarian cancer screening, Cancer, 71, pp. 1523-1528, (1993)
[12]
Weiner Z., Thaler I., Beck D., Et al., Differentiating malignant from benign ovarian tumors with transvaginal colow flow imaging, Obstet Gynecol, 79, pp. 159-162, (1992)
[13]
Narod S.A., Risch H., Moslehi R., Et al., Oral contraceptives and the risk of hereditary ovarian cancer, NEJM, 339, pp. 424-428, (1998)
[14]
Lerman C., Daly M., Masny G., Balshem A., Attitudes about genetic testing for breast-ovarian cancer susceptibility, J Clin Oncol, 12, pp. 843-850, (1994)
[15]
Lerman C., Croyle R., Psychological issues in genetic testing for breast cancer susceptibility, Arch Intern Med, 154, pp. 609-616, (1994)
[16]
Lynch H.T., Lemon S.J., Durham C., Et al., A descriptive study of BRCA1 testing and reactions to disclosure of test results, Cancer, 79, pp. 2219-2228, (1997)
[17]
Rozario D., Brown I., Fung Kee Fung M., Temple L., Is incidental prophylactic oophorectomy an acceptable means to reduce the incidence of ovarian cancer?, Am J Surgery, 173, pp. 495-498, (1997)
[18]
Aziz S., Kuperstein G., Rosen B., Et al., A genetic epidemiology study of carcinoma of the Fallopian Tube, Gynecol Oncol, 80, pp. 341-345, (2001)